摘要
[目的]探讨髋关节置换术后股骨大粗隆滑囊炎糖皮质激素注射治疗的疗效及非手术治疗失败的可能危险因素。[方法]通过随访2003年3月～2009年4月本科收治的术后股骨大粗隆滑囊炎患者24例27髋的治疗情况,并结合临床特点分析非手术治疗失败的可能危险因素。[结果]经糖皮质激素注射治疗后,21例股骨大粗隆滑囊炎疼痛得到缓解,缓解率为78%。治疗预后与患者的年龄、体重指数、肢体不等长有关(P<0.05),而与患者的性别、手术入路无关。[结论]糖皮质激素注射治疗对全髋关节置换术后股骨大粗隆滑囊炎是有效的,同时在年轻患者、肥胖者及肢体短缩者中治疗效果一般。
[Objective]To examine the therapeutic effect of corticosteroid injection as treatment for post-arthoplasty trochanteric bursitis and the risk factors for failure of nonoperative treatment.[Methods]From March 2003 to April 2009,24 patients（27 hip） were followed-up.Combined with the clinical features of patients,we analyzed the risk factors for failure of nonoperative treatment.[Results]Symptoms were relieved in 21 hips（78%） after corticosteroid injection.We found a significant correlation between prognosis and age,BMI and leg-length discrepancy,but no correlation between gender and operative approach.[Conclusion]Corticosteroid injection is an effective treatment for postarthoplasty trochanteric bursitis.The failure of medical treatment usually focuses on fatter or younger patients or those with leg-length discrepancy.
出处
《中国矫形外科杂志》
CAS
CSCD
北大核心
2011年第9期728-730,共3页
Orthopedic Journal of China
